Last reviewed · How we verify

NCT04558671: RESPIRE

Preschool Bronchial Remodeling and Risk of Exacerbation

Completed Last updated 29 September 2020
What this trial tests

trial testing asthma exacerbations in Preschool Severe Asthma in 56 participants. Completed in 24 September 2020.

Timeline
16 September 2020
Primary endpoint
24 September 2020
24 September 2020

Quick facts

Lead sponsorUniversity Hospital, Bordeaux
StatusCompleted
Study typeOBSERVATIONAL
Enrollment56
Start date16 September 2020
Primary completion24 September 2020
Estimated completion24 September 2020
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bordeaux

Who can join

Adults 1 to 5, any sex, with Preschool Severe Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bronchial remodeling is an abnormal tissue repair process of the bronchial wall components that characterizes severe asthma which can include epithelial abrasion, thickening of the reticular basement membrane (RBM), an increase in bronchial fibrosis, blood vessel count, mucosal gland mass and/or bronchial smooth muscle (BSM) mass. We identified using latent class analysis two classes of patients. Compared to the second class, the first class was characterized by an increase in RBM thickness, blood vessel count, BSM mass and a decrease in RBM-BSM distance, mucus gland mass and bronchial fibrosis. We then hypothesized that this first latent class identified children at risk of asthma exacerbations.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Bronchial Remodeling-based Latent Class Analysis Predicts Exacerbations in Severe Preschool Wheezers.
    Fayon M, Beaufils F, Esteves P, Campagnac M, et al · · 2023 · cited 19× · PMID 36108144 · DOI 10.1164/rccm.202205-0913oc

Verify or expand the search:

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04558671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing